Drug Target Identification Using Side-Effect Similarity
Top Cited Papers
- 11 July 2008
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 321 (5886) , 263-266
- https://doi.org/10.1126/science.1158140
Abstract
Targets for drugs have so far been predicted on the basis of molecular or cellular features, for example, by exploiting similarity in chemical structure or in activity across cell lines. We used phenotypic side-effect similarities to infer whether two drugs share a target. Applied to 746 marketed drugs, a network of 1018 side effect–driven drug-drug relations became apparent, 261 of which are formed by chemically dissimilar drugs from different therapeutic indications. We experimentally tested 20 of these unexpected drug-drug relations and validated 13 implied drug-target relations by in vitro binding assays, of which 11 reveal inhibition constants equal to less than 10 micromolar. Nine of these were tested and confirmed in cell assays, documenting the feasibility of using phenotypic information to infer molecular interactions and hinting at new uses of marketed drugs.Keywords
This publication has 25 references indexed in Scilit:
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- Large‐scale prediction of drug–target relationshipsFEBS Letters, 2008
- Analysis of System Structure–Function RelationshipsChemMedChem, 2007
- SuperTarget and Matador: resources for exploring drug-target relationshipsNucleic Acids Research, 2007
- Global mapping of pharmacological spaceNature Biotechnology, 2006
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Similarity Metrics for Ligands Reflecting the Similarity of the Target ProteinsJournal of Chemical Information and Computer Sciences, 2002
- Do Structurally Similar Molecules Have Similar Biological Activity?Journal of Medicinal Chemistry, 2002
- The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?The Neuroscientist, 2000
- Volume changes in protein evolutionJournal of Molecular Biology, 1994